社会经济地位与动脉样硬化心血管疾病风险估计之间的关联:基于中年人口的研究结果
1Department of Epidemiology-Data-Biostatistics, Foch Hospital, Suresnes, 92150, France.
Public health
|June 18, 2023
概括
更高的社会经济地位 (SES) 与降低心血管疾病 (CVD) 风险有关. 这项研究发现,收入,教育和就业在英国生物库人口中显著降低了动脉样硬化心血管疾病风险.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 心血管医学 心血管医学
背景情况:
- 社会经济地位 (SES) 和心血管疾病 (CVD) 风险相关性研究不足.
- 了解这种联系对于有针对性的公共卫生干预至关重要.
研究的目的:
- 调查SES与估计的10年动脉样硬化心血管疾病 (ASCVD) 风险之间的关系.
- 分析英国生物库人口中的SES因素.
主要方法:
- 基于人口的研究,使用来自311,928名志愿者的英国生物库数据.
- 通过问卷评估SES;ASCVD风险用聚合队列方程计算.
- 多个性别特定的物流回归分析了SES和ASCVD风险之间的关联.
主要成果:
- 男性的整体ASCVD风险高于女性.
- 较高的收入,教育,就业和较低的贫困 (Townsend五分位数) 与两种性别的10年ASCVD风险降低有关.
- 证实SES因素对心血管疾病风险的贡献与生活方式因素相当.
结论:
- 卫生政策应将已识别的SES因素与传统风险因素一起纳入心血管疾病预防战略.
- 需要进一步的研究来完善ASCVD风险预测模型,包括各种SES变量.
相关概念视频
Coronary Artery Disease I: Introduction
33
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33
Atherosclerosis I: Introduction
13
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
16
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
16
Psychoneuroimmunology: Cardiovascular Disease
56
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
56
Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25


